| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2022 | MTD Mettler Toledo International Inc/ | Spoerry Robert F70 | Director | Sell | 1,000 | $1,365.00 | $1,365,000.00 | -13.5% | +6.2% | -9.1% | |
| Aug 12, 2022 | GH Guardant Health, Inc. | Merrill Amelia | SVP, People | Sell | 9,000 | $53.85 | $484,665.75 | -16.7% | -9.1% | -34.3% | |
| Aug 12, 2022 | WGS Genedx Holdings Corp. | Assad Shawn82 | Former CAO | Sell | 4,663 | $1.90 | $8,844.31 | -5.6% | -61.5% | -93.4% | |
| Aug 11, 2022 | CDNA Caredx, Inc. | Maag Peter84 | Director | Sell | 20,000 | $24.66 | $493,143.27 | -3.2% | -35.5% | -61.3% | |
| Aug 10, 2022 | MTD Mettler Toledo International Inc/ | Filliol Olivier A71 | Director | Sell | 8,279 | $1,341.34 | $11,104,932.71 | -11.7% | +0.3% | -7.5% | |
| Aug 10, 2022 | CDNA Caredx, Inc. | Colon Grace71 | Director | Sell | 2,521 | $24.81 | $62,546.01 | -34.1% | -34.6% | -61.4% | |
| Aug 9, 2022 | MTD Mettler Toledo International Inc/ | Keller Gerry64 | Head Of Process Analytics | Sell | 450 | $1,318.83 | $593,474.00 | -59.2% | -1.2% | -5.3% | |
| Aug 9, 2022 | BDSX Biodesix Inc | Siurek Ryan H64 | Chief Accounting Officer | Sell | 1,645 | $2.53 | $4,158.89 | -12.8% | -55.6% | -44.0% | |
| Aug 9, 2022 | BDSX Biodesix Inc | O'Kane Kieran64 | Chief Commercial Officer | Sell | 1,673 | $2.53 | $4,229.68 | -12.8% | -55.6% | -44.0% | |
| Aug 9, 2022 | BDSX Biodesix Inc | Georgantas Robert William III | Chief Scientific Officer | Sell | 1,686 | $2.53 | $4,262.55 | -7.0% | -55.6% | -44.0% | |
| Aug 9, 2022 | BDSX Biodesix Inc | Cowie Robin Harper62 | CFO, Sec'y &Treasurer | Sell | 3,533 | $2.53 | $8,932.13 | -5.0% | -55.6% | -44.0% | |
| Aug 9, 2022 | WGS Genedx Holdings Corp. | Ro Isaac89 | Former CFO | Sell | 20,245 | $1.99 | $40,216.69 | -7.7% | -48.3% | -90.4% | |
| Aug 9, 2022 | BDSX Biodesix Inc | Pestano Gary Anthony65 | Chief Development Officer | Sell | 1,549 | $2.53 | $3,916.18 | -1.7% | -55.6% | -44.0% | |
| Aug 9, 2022 | BDSX Biodesix Inc | Hutton Scott59 | President &CEO | Sell | 13,634 | $2.53 | $34,469.48 | -15.4% | -55.6% | -44.0% | |
| Aug 8, 2022 | TMO Thermo Fisher Scientific Inc. | Boxer Michael A59 | SVP And General Counsel | Sell | 7,283 | $590.80 | $4,302,796.40 | -37.0% | -15.7% | -4.7% | |
| Aug 8, 2022 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Executive Chairwoman | Sell | 121,917 | $27.56 | $3,360,445.01 | -23.9% | -7.8% | -6.8% | |
| Aug 5, 2022 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 350,000 | $2.29 | $802,103.17 | - | -21.1% | -12.7% | |
| Aug 5, 2022 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 1,558 | $30.31 | $47,222.98 | -0.2% | -20.6% | -39.5% | |
| Aug 5, 2022 | BIO Bio-Rad Laboratories, Inc. | Ramalingam Ajit59 | SVP, Chief Accounting Officer | Sell | 518 | $537.00 | $278,166.00 | -84.0% | -32.3% | -25.9% | |
| Aug 5, 2022 | VCYT Veracyte, Inc. | Kennedy Giulia C78 | Chief Scientific &Med Officer | Sell | 1,028 | $26.54 | $27,283.12 | -1.4% | -13.2% | -8.4% | |
| Aug 5, 2022 | EXAS Exact Sciences Corp | Baranick Brian75 | Gen. Mgr., Precision Oncology | Sell | 984 | $47.12 | $46,366.08 | -17.6% | -31.3% | +81.2% | |
| Aug 5, 2022 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 200 | $226.13 | $45,226.82 | -1.0% | -2.8% | -7.4% | |
| Aug 4, 2022 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 8,450 | $30.73 | $259,638.27 | -0.4% | -20.3% | -40.4% | |
| Aug 4, 2022 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 20,000 | $589.02 | $11,780,389.86 | -0.7% | -16.7% | -6.9% | |
| Aug 3, 2022 | MTD Mettler Toledo International Inc/ | Spoerry Robert F70 | Director | Sell | 2,000 | $1,362.50 | $2,725,000.00 | -13.5% | -5.8% | -6.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.